MRVI Stock News & Catalysts – Maravai LifeSciences

FEATURED

Maravai LifeSciences Reports Third Quarter 2026 Financial Results

Third quarter 2026 total revenue up 10% from prior year mRNA revenue up 28% year-over-year Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ:MRVI), a global provider of life science reagents and services to

Summary

Nov 4, 2026, 4:01 PM ·Business Wire

RECENT

Maravai LifeSciences Announces November 2026 Investor Conference Schedule

Maravai LifeSciences, Inc. (NASDAQ:MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conference during the month

Oct 29, 2026, 4:01 PM ·Business Wire

Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 4, 2026

Maravai LifeSciences, Inc. (Maravai) (NASDAQ:MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its third quarter financial and operating results

Oct 14, 2026, 4:01 PM ·Business Wire

TriLink BioTechnologies® Secures Additional China Patent for CleanCap® Technology, Adding Broad Composition-of-Matter Protection to Reinforce Its Global IP

New Patent Protects the CleanCap® Cap Analog Compounds Themselves and mRNA-Based Pharmaceutical Compositions — Extending Beyond Method Claims to Cover the Molecules at the Heart of Modern mRNA Medicines TriLink

Sep 29, 2026, 4:01 PM ·Business Wire

Maravai LifeSciences Reports Second Quarter 2026 Financial Results

Second quarter 2026 total revenue up 9% from prior year Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ:MRVI), a global provider of life science reagents and services to researchers and biotech innovators,

Aug 6, 2026, 4:01 PM ·Business Wire

Maravai LifeSciences To Host Earnings Conference Call on Thursday, August 6, 2026

Maravai LifeSciences, Inc. (Maravai) (NASDAQ:MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its second quarter financial and operating results

Jul 22, 2026, 4:02 PM ·Business Wire

TriLink BioTechnologies® Further Strengthens Global IP Position with Newly Issued Patent in China for CleanCap® Capping Technology

TriLink's Complete Portfolio of CleanCap® Analogs are Patented in Major Jurisdictions Globally; TriLink is the Sole Authorized Manufacturer of CleanCap® Capping Analogs TriLink BioTechnologies, LLC (TriLink®), a

Jul 20, 2026, 4:02 PM ·Business Wire

TriLink Opens GMP Enzyme Manufacturing Facility, Enabling Integrated IVT Supply from R&D to Commercial Scale

New Jupiter, FL facility enables RNA therapeutics developers to source critical manufacturing materials from a single, coordinated supplier, simplifying workflows and accelerating development timelines. TriLink, part

Jun 16, 2026, 8:30 AM ·Business Wire

Maravai LifeSciences Announces Refinancing of Credit Agreement, Extending Maturity to 2032

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced that certain of its subsidiaries have entered into a new

Jun 3, 2026, 8:30 AM ·Business Wire

Maravai LifeSciences To Attend The Jefferies Global Healthcare Conference

Maravai LifeSciences, Inc. (NASDAQ:MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced that the Company will participate in the following investor

May 18, 2026, 4:00 PM ·Business Wire

Maravai LifeSciences Reports First Quarter 2026 Financial Results

First quarter 2026 total revenue up 41% from prior year Base revenue excluding revenue for high-volume CleanCap for commercialized COVID-19 vaccines up 10% from prior year Maravai LifeSciences Holdings, Inc.

May 7, 2026, 4:01 PM ·Business Wire

Maravai LifeSciences To Host Earnings Conference Call on Thursday, May 7, 2026

Maravai LifeSciences, Inc. (Maravai) (NASDAQ:MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its first quarter 2026 financial and operating results

Apr 20, 2026, 4:05 PM ·Business Wire

Maravai Lifesciences Reports Fourth Quarter and Full Year 2025 Financial Results

Organizational restructuring and operating cost reduction ahead of plan Focus on operational excellence, revenue growth, and improving Adjusted EBITDA Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ:MRVI), a

Feb 25, 2026, 4:01 PM ·Business Wire

Maravai LifeSciences To Host Earnings Conference Call on Wednesday, February 25, 2026

Maravai LifeSciences, Inc. (Maravai) (NASDAQ:MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its fourth quarter and full year 2025 financial and

Feb 9, 2026, 5:05 PM ·Business Wire

Maravai LifeSciences Announces November 2025 Investor Conference Schedule

Nov 10, 2025, 8:00 AM ·Business Wire

Maravai LifeSciences Holdings, Inc. MRVI · News